Steven B Ketchum

CIK 1289884 · EVP, Chief Scientific Officer · last filed 2026-02-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$623.0K

Companies

3

Total Filings

87

Lifetime Open-Market Net

-$24.75M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMRN EVP, Chief Scientific Officer 40,879 $15.24 $623.0K -$24.80M 69 2026-02-03
Viracta Therapeutics, Inc. (SNSS) Delisted Director 86,378 $18.62 $1.61M $43.5K 17 2020-07-01
Viracta Therapeutics, Inc. (SNSSD) Delisted Sr. Vice President, R & D 72,921 $0 1 2011-03-02

Recent Filings · Page 7 of 9

87 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-01-16 AMRN Mixed -$6.2K EDGAR
2018-01-09 AMRN Mixed -$152.7K EDGAR
2018-01-04 AMRN Mixed -$391.5K EDGAR
2017-10-06 AMRN Sell (S) −63,479 -$221.2K EDGAR
2017-07-03 AMRN Grant (A) $0 EDGAR
2017-06-02 Viracta Therapeutics, Inc. (SNSS) Delisted Grant (A) $0 EDGAR
2017-02-02 AMRN Mixed +73,869 -$208.6K EDGAR
2016-07-05 Viracta Therapeutics, Inc. (SNSS) Delisted Grant (A) $0 EDGAR
2016-02-02 AMRN Mixed +74,907 -$57.8K EDGAR
2015-07-28 Viracta Therapeutics, Inc. (SNSS) Delisted Mixed +10,298 -$3 EDGAR
Showing 6170 of 87
Page 7 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.